Novagali Pharma is an emerging ophthalmic pharmaceutical company that develops innovative products for all segments of the eye.
EVRY- May 05, 2009 - Novagali Pharma announces FDA Clearance of IND for phase III of Catioprost®, its cationic emulsion of Latanoprost in patients with Glaucoma
Read more
EVRY – 15 April 2009 Novagali Pharma completed a new Phase II with Cyclokat® in dry eye.
EVRY – 8 June 2009 Novagali Pharma receives the “Health Award” from Siemens for Novasorb®, its cationic emulsion proprietary technology platform.
EVRY- March 19, 2009 - Frost
& Sullivan Recognizes Novagali Pharma for Innovation in Ophthalmic
Therapies, with the 2009 North American Frost & Sullivan Award for
Industry Innovation & Advancement of the Year Read more
An innovative cationic emulsion to relieve dry eye sensation
of the eye surface
Read more
Our commitment to make our site accessible to anyone is based on the WCAG standards. Would you have any suggestion or request do not hesitate to contact us: Make a suggestion.
